Dyloject FDA Approval History
FDA Approved: Yes (Discontinued) (First approved December 23, 2014)
Brand name: Dyloject
Generic name: diclofenac sodium
Dosage form: Injection
Company: Pfizer Inc.
Treatment for: Pain
Marketing Status: Discontinued
Dyloject (diclofenac sodium injection) is an intravenous non-steroidal anti-inflammatory drug (NSAID) for the management of acute moderate-to-severe pain in adults.
Development timeline for Dyloject
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.